Jump to main content
博士論文

Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases

Persistent ID (NDL)
info:ndljp/pid/11711569
Material type
博士論文
Author
猿渡, 功一ほか
Publisher
熊本大学
Publication date
2020-12-07
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
熊本大学,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Notes on use

Note (General):

元資料の権利情報 : (C)2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
猿渡, 功一
Koichi, Saruwatari
Publication, Distribution, etc.
Publication Date
2020-12-07
Publication Date (W3CDTF)
2020-12-07
Alternative Title
Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases
脳転移を有するEGFR遺伝子変異陽性非小細胞肺癌に対して頭蓋内放射線療法の先行とそれに続くエルロチニブは、臨床転帰に良好な影響を与える
Degree grantor/type
熊本大学
Date Granted
2020-12-07